Scale of UK procurement waste casts new doubt over NHS reforms
This article was originally published in Clinica
New evidence indicates that decentralised medtech procurement is causing significant waste. The revelations cast new doubts on the ability of an increasingly fragmented UK National Health Service (NHS) to achieve the significant economies that the government is seeking.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.